Sponsor pipeline

Genecombio Ltd. clinical trial pipeline

2 active trials 0 recruiting 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days

2026-09-12

Primary completion pushed: 2026-12 → 2027-12

NCT06772402 GCB-001 in Treatment of Patients With Type II (SMA) Spinal Muscular Atrophy

2026-09-12

Primary completion pushed: 2026-12 → 2027-12

NCT06739434 GCB-002 in Treatment of Patients With Rett Syndrome

Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Not applicable
NCT06739434	GCB-002 in Treatment of Patients With Rett Syndrome	RETT Syndrome With Proven MECP2 Mutation	Enrolling by Invitation	2026-09-15
NCT06772402	GCB-001 in Treatment of Patients With Type II (SMA) Spinal Muscular Atrophy	Spinal Muscular Atrophy Type 2	Enrolling by Invitation	2026-09-11

Get alerts when Genecombio Ltd.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.